Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results f...

por Naismith, Robert T., Wundes, Annette, Ziemssen, Tjalf, Jasinska, Elzbieta, Freedman, Mark S., Lembo, Anthony J., Selmaj, Krzysztof, Bidollari, Ilda, Chen, Hailu, Hanna, Jerome, Leigh-Pemberton, Richard, Lopez-Bresnahan, Maria, Lyons, Jennifer, Miller, Catherine, Rezendes, David, Wolinsky, Jerry S.
Publicado 2020

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

por Naismith, Robert T, Wolinsky, Jerry S, Wundes, Annette, LaGanke, Christopher, Arnold, Douglas L, Obradovic, Dragana, Freedman, Mark S, Gudesblatt, Mark, Ziemssen, Tjalf, Kandinov, Boris, Bidollari, Ilda, Lopez-Bresnahan, Maria, Nangia, Narinder, Rezendes, David, Yang, Lili, Chen, Hailu, Liu, Shifang, Hanna, Jerome, Miller, Catherine, Leigh-Pemberton, Richard
Publicado 2019

P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL

por Gotlib, Jason, Castells, Mariana, Oude Elberink, Hanneke, Siebenhaar, Frank, Hartmann, Karin, Broesby-Olsen, Sigurd, George, Tracy I., Panse, Jens, Alvarez-Twose, Ivan, Radia, Deepti, Tashi, Tsewang, Bulai Livideanu, Cristina, Sabato, Vito, Van Daele, Paul, Cerquozzi, Sonia, Dybedal, Ingunn, Reiter, Andreas, Ustun, Celalettin, Schafhausen, Philippe, Bose, Prithviraj, Deangelo, Daniel J., Rein, Lindsay, Vachhani, Pankit, Triggiani, Massimo, Rafferty, Mark, Butt, Nauman, Oh, Stephen, Wortmann, Friederike, Ungerstedt, Johanna, Taparia, Minakshi, Kuykendall, Andrew T., Arana Yi, Cecilia, Mattsson, Mattias, Shomali, William, Giannetti, Matthew, Bidollari, Ilda, Lin, Hui-Min, Scherber, Robyn, Roche, Maria, Akin, Cem, Maurer, Marcus
Publicado 2023